LOGIN  |  REGISTER
Chimerix

DaVita (NYSE: DVA) Stock Quote

Last Trade: US$130.42 -0.98 -0.75
Volume: 482,026
5-Day Change: -1.90%
YTD Change: 24.49%
Market Cap: US$11.390B

Latest News From DaVita

HealthStocksHub
DENVER , April 10, 2024 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin , to join the Board, effective April 10, 2024 . "We're pleased to welcome Dennis to DaVita's board," said Pamela Arway , independent chair of the DaVita Inc. Board of... Read More
Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month DENVER , March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two... Read More
DENVER , March 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason , will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024 , at 8:00 a.m. EDT . To view the live webcast, visit the Barclays page and create a free registration.... Read More
Expansion would make DaVita the largest dialysis services provider in Latin America DENVER , March 5, 2024 /CNW/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia , and its entry into Chile and Ecuador . The deal, which is consistent with DaVita's disciplined investment strategy, involves... Read More
DENVER , Feb. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason , will participate in a fireside chat with investors at TD Cowen's Health Care Conference 2024 on Monday, March 4, 2024 , at 11:10 a.m. EST . To view the live webcast, visit the TD Cowen page and create a free registration. About... Read More
DENVER , Feb. 13, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023 . "As we reflect on the past year, our 2023 financial performance highlighted the resilience of our business," said Javier Rodriguez , CEO of DaVita Inc. "The external challenges of recent years ultimately made us stronger, and with continued investment in our teammates,... Read More
DENVER , Jan. 23, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Tuesday, February... Read More
Funding to support co-created 'Start Early' program aimed at increasing degree completion rates DENVER , Dec. 19, 2023 /PRNewswire/ -- The DaVita G iving Foundation has awarded Western Governors University's (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in Start Early , a program co-created by DaVita Inc. and WGU to help increase... Read More
Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER , Nov. 30, 2023 /PRNewswire/ -- DaVita , a leading provider of kidney care services, today announced the success of its 2023 Move It With Purpose (MIWP) event. MIWP is an annual community-driven initiative that brings together DaVita teammates, friends, family members, and the kidney care community to support... Read More
DENVER , Nov. 7, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023 . "We delivered another strong quarter," said Javier Rodriguez , CEO of DaVita Inc. "We began the year by making progress earlier than expected across many of our key operating priorities, and that momentum has continued into the third quarter. We have balanced a strong focus on... Read More
Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA , Nov. 2, 2023 /PRNewswire/ -- DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc. , is presenting the findings of five new research projects at the American Society of Nephrology (ASN)'s annual "Kidney Week," which... Read More
Kidney care provider harnesses the power of Google Cloud's leading-edge infrastructure, AI, and analytics tools to help improve care plans and streamline clinical workflows SUNNYVALE, Calif. , Oct. 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) and Google Cloud today announced that the organizations have collaborated to create a new clinical operating system that sets a foundation for streamlined kidney care for more than... Read More
DENVER , Oct. 17, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Tuesday, November 7,... Read More
DENVER , Oct. 12, 2023 /PRNewswire/ -- DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes, related to its FLOW study that sought to demonstrate that Ozempic delays progression of chronic kidney disease (CKD) and lowers the risk of kidney and cardiovascular mortality. The following... Read More
Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER , Sept. 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services, today announced the launch of its 2023 Health Tour, a mobile health screening and kidney care education program supporting local communities across the country. The tour will... Read More
Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER , Sept. 12, 2023 /PRNewswire/ -- DaVita Inc. , a leading kidney care provider, has joined forces with Adtalem Global Education, to launch the "Introduction to Nephrology Nursing" curriculum as a part of the Practice Ready. Specialty Focused. ™ (PRSF) initiative at one of its institutions, Chamberlain... Read More
DENVER , Sept. 11, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat hosted by UBS on Thursday, September 14, 2023 , at 11:30 am EDT . To view the live webcast, visit the UBS page here and create a free registration. About DaVita Inc. DaVita (NYSE: DVA) is a health... Read More
DENVER , Aug. 3, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2023. "Over the first half of the year, DaVita has been focused on innovation in our clinical systems and driving operational improvements throughout our organization," said Javier Rodriguez , CEO of DaVita Inc. "Our second quarter performance reflects strong traction across those... Read More
DENVER , July 13, 2023 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors appointed a new independent director, Wendy Schoppert , to join the Board, effective as of July 14, 2023 . "We're pleased to welcome Wendy to DaVita's board," said Pam Arway , independent chair of the DaVita Inc. Board of Directors. "Her proven track record and broad corporate and board expertise will positively impact our... Read More
DENVER , July 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 3rd, 2023 , at 5:00 p.m. Eastern Time . The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Thursday, August... Read More
Recognizes nurses who further DaVita's mission to be the provider and employer of choice. DENVER , May 10, 2023 /PRNewswire/ -- DaVita Inc . today announced that 56 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of the DAISY Foundation's mission to recognize nurses who provide outstanding, compassionate care in more than 5,800 health care... Read More
DENVER , May 8, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2023. "In the first quarter, we performed well on our key metrics and our results benefited from an improving macro environment," said Javier Rodriguez , CEO of DaVita Inc. "While some external uncertainty remains, 2023 is off to a strong start and the continuation of current trends would put... Read More
DENVER , May 4, 2023 /PRNewswire/ -- DaVita Inc. today published its 2022 Community Care Report , reinforcing its long-standing commitment to corporate citizenship and highlighting meaningful progress made toward meeting the 2025 environmental, social and governance (ESG) goals it set in 2021. Guided by its Trilogy of Care – Caring for Our Patients, Caring for Each Other and Caring for Our World – DaVita's ambitious,... Read More
DENVER , May 2, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the BofA Securities Healthcare Conference 2023 on Wednesday, May 10, 2023, at 4:40 p.m. EDT. To view the live webcast, visit the BofA Securities page here and create a free registration. DaVita (NYSE: DVA) is a health care provider focused on... Read More
DENVER , April 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023 , at 5:00 p.m. Eastern Time . The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Monday, May 8, 2023... Read More
DENVER , March 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on Tuesday, March 14, 2023, at 3:05 p.m. EDT. To view the live webcast, visit the Barclays page here and create a free registration. DaVita (NYSE: DVA) is a health care provider focused on... Read More
The event has raised nearly $15 million for the nonprofit since 2007, enabling Bridge of Life to enhance kidney care globally through its medical missions. DENVER , Dec. 20, 2022 /PRNewswire/ -- Today, DaVita announced that over 4,400 DaVita teammates, friends, family and key members of the kidney care community joined together to participate in the inaugural Move It with Purpose (MIWP) event to benefit Bridge of Life , a... Read More
Compass Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB